NASDAQ:NVCR

Novocure Stock Predictions

Healthcare > Medical - Instruments & Supplies

Buy NVCR

*Your capital is at risk

$16.15

+0.330 (+2.09%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

NVCR Prediction Chart

NVCR Predictions History

Latest community submissions for NVCR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jul 18, 2017	$17.85 -4.80%	$18.75	X	95.20%	0
Bull4now	Jul 18, 2017	$18.55 -1.07%	$18.75	X	98.90%	1
JS Pro	Mar 30, 2017	$8.20 +1.86%	$8.05	X	98.10%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVCR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT NOVOCURE LIMITED

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by